Disclosure 0001763494-26-000008-5

SEC FORM 4

$4,313,403.36

Travere Therapeutics, Inc. (TVTX)

Sale of 78,400 shares at $55.0179 per share.

Reporting Person Dube Eric M · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001763494-26-000008 · filed 2026-10-19 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Travere Therapeutics, Inc. (TVTX)." Disclosed 2026-10-19. https://desqlong.com/cards/0001763494-26-000008-5 (retrieved 2026-10-20).